Market Overview

KASKELA LAW LLC: Shareholder Class Action Lawsuit Filed Against ACADIA Pharmaceuticals Inc.

Share:

Kaskela Law LLC announces that a shareholder class action lawsuit has
been filed against ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ("ACADIA"
or the "Company") on behalf of purchasers of the Company's securities
between April 29, 2016 and July 9, 2018
, inclusive (the "Class
Period").

ACADIA investors are encouraged to contact Kaskela Law LLC (D.
Seamus Kaskela, Esq.) at (484) 258 – 1585 or (888) 715 – 1740 for
additional information about this action and/or to discuss their legal
rights and options.
Investors may also register their
information with the firm at
http://kaskelalaw.com/case/acadia/.

ACADIA is a biopharmaceutical company focused on the development and
commercialization of innovative medicines to address unmet medical needs
in central nervous system disorders. One of ACADIA's products is
NUPLAZID (pimavanserin), which was approved by the U.S. Food and Drug
Administration ("FDA") in April 2016 for the treatment of hallucinations
and delusions associated with Parkinson's disease.

The shareholder class action complaint alleges that ACADIA and certain
other defendants made a series of false and misleading statements during
the Class Period and failed to disclose material adverse facts to
investors about the Company's business, operations and prospects. Among
other things, the defendants failed to disclose: (i) that adverse events
and safety concerns related to NUPLAZID threatened the drug's initial
and continuing FDA approval; and (ii) that ACADIA engaged in business
practices likely to attract regulatory scrutiny. The complaint further
alleges that, as a result of the foregoing, investors purchased ACADIA's
securities at artificially inflated prices during the Class Period, and
suffered significant investment losses as a result of the defendants'
conduct.

IMPORTANT DEADLINE: Investors who purchased ACADIA's
securities during the Class Period may, no
later than September 17, 2018
, seek to be appointed as a
lead plaintiff of the investor class. ACADIA investors are encouraged to
contact Kaskela Law LLC for additional information about this action
and/or to discuss their legal rights and options, or to register their
information with the firm at http://kaskelalaw.com/case/acadia/.

Kaskela Law LLC exclusively represents investors in state and federal
courts throughout the country. For additional information about Kaskela
Law LLC please visit www.kaskelalaw.com.

View Comments and Join the Discussion!